In glioma cells, the transmission of extracellular vesicles (EVs) containing the oncogenic receptor epidermal growth factor receptor variant III (EGFRvIII) to adjacent glioma cells lacking the receptor triggers the activation of the AKT pathway. The gene discussed is AKT1; the disease is central nervous system cancer.